Canopy’s $350M Hiku Acquisition Underscores the Value of Cannabis Brands


Ryan Allway

July 17th, 2018

Exclusive, News, Top Story


Cannabis producers may have been the best investment opportunities in the early phases of the industry, but retail and brands are quickly growing in importance as the market evolves. Today, investors have real access to businesses across higher-value areas of the supply chain than growers. Last week’s announcement regarding Canopy Growth Corp.’s (TSX: WEED) (NYSE: CGC) $350 million (fully diluted) acquisition of Hiku Brands Co. Ltd. (CSE: HIKU) — owner of the Tokyo Smoke chain of coffee shops in Canada — underscores this new trend.

Hiku has a handful of coffee shops in Ontario that sell cannabis accessories, but it won’t be allowed to sell adult-use marijuana in the province unless Premier Doug Ford changes the rules. The company also has a shop in Calgary. The only clear path Hiku has to selling legal cannabis is in their 10 locations in the Province of Manitoba with a population of 1.3 million. The company has applied to open stores in Alberta, population 4.3 million, and is working with an applicant to open stores in Newfoundland, population 0.5 million.

Canopy Growth acquired Hiku to strengthen its retail and brand portfolio. While Hiku was already set to merge with another licensed producer, which required a $10 million break-up fee, Canopy Growth went over the top to own Hiku’s brands. This is a sign of how competitive the cannabis industry has become in recent months, on the heels of the two pre-eminent cannabis companies in the U.S. going public: Green Thumb Industries Inc. (CSE: GTII) and MedMen Enterprises Inc. (CSE: MMEN) (OTCQB: MMNFF).

MedMen appears particularly well-positioned as a branding machine; having built to date one of the most recognized brands in the industry, being dubbed “the Starbucks of Weed” and drawing comparisons to Apple Stores.  At the core of MedMen’s success has been their marquee retail locations in the most iconic shopping districts in the United States. The company currently has 13 stores in three states and licenses for 45 in 5 States which the company says will all be open by 2020, plus five large scale cultivation and manufacturing facilities.

MedMen 5th Avenue Retail Store, New York

The current MedMen stores are located in Tier 1 markets in California, Nevada and New York.  These three markets collectively address 383 million potential customers based on demographic data compared to 44 million in Canada. By putting the stores in high profile shopping districts such as Los Angeles’ Abbot Kinney, Beverly Hills, near the Las Vegas Strip, Downtown Las Vegas and New York’s Fifth Avenue, MedMen is creating a dominant retail brand that is building equity with the consumers of this emerging industry.

Transaction Highlights Value of MedMen’s Assets

While establishing its robust retail presence and brand, MedMen aims to control the entire supply chain in all the markets where it operates. The company has its own production facilities capable of producing about 5,000 kg/year currently. Next year, the company will be going live on a new facility in California that will double its production capacity. Owning the entire vertical gives MedMen leverage against vendors and the ability to build and distribute product brands consistently across the U.S.  In the U.S., cannabis cannot cross state lines so products must be produced and consumed inside each state. With factories and retail presence in every market, MedMen is uniquely positioned to manufacture and distribute nationally branded products consistently.

It is a model the company plans on replicating in all the markets it enters. In early June, the company announced that it secured one of 13 licenses in Florida with the right to open 25 dispensaries. Florida is the country’s fourth most populous state with a thriving medical marijuana program and one of the largest addressable markets in the world.

The verdict is still out on who will own the U.S. market, but MedMen has a large head start. The Florida acquisition is proving that going public has only added velocity to the execution of its strategy.

Looking Ahead

Canopy Growth’s willingness to pay $350 million for a brand with a retail niche in a small Canadian market suggests that companies like MedMen — with presence in major U.S. markets, with cultivation and manufacturing to boot — hold tremendous value.

Key U.S. cannabis markets where MedMen operates, such as California and Nevada, already offer a full spectrum of cannabis products legally to consumers, whereas the Canadian industry will start with limited varieties.  There is a clear pathway to supporting states’ rights to legalize cannabis and the majority of the public supports legalization in the U.S. Accordingly, U.S. investments could offer a better value than Canadian investments given their lower valuations when looking at tangible revenue growth and earnings.

For more information about MedMen, visit the company’s website or download their investor presentation.

Disclaimer  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading